ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Alibaba shares rise after Jack Ma buys $76.5 million stake

Founder's purchase of HK$600 million in Hong Kong-listed shares follows a 10% drop after a $10.2 billion share offering. Insiders Joe Tsai and Eddie Wu also bought shares.

PA
Priya Anand · Equities & Earnings Desk · 31 Aug 2026 · 20:07 · 1 min read
Share
Alibaba shares rise after Jack Ma buys $76.5 million stake

Alibaba Group's Hong Kong-listed shares climbed 1.4% to HK$115.80 on Wednesday after founder Jack Ma purchased more than HK$600 million (US$76.5 million) in stock.

The purchase by Ma follows a 10% intraday decline in Alibaba shares on Monday after the company announced a HK$80 billion (US$10.2 billion) primary share offering priced at an 8.4% discount to the prior close. The offering, which totals 710 million new shares at HK$112.70 each, is the largest follow-on issuance by a Hong Kong-listed company on record.

Chairman Joe Tsai and Chief Executive Officer Eddie Wu also increased their exposure, with Tsai acquiring HK$82 million in shares on Tuesday following HK$80 million in purchases on Monday. Wu bought approximately HK$40 million on Monday. Combined, the insider purchases total HK$202 million over two days.

The share offering, announced on August 23, contributed to a broader decline in Alibaba's stock, which had already fallen 75% in quarterly net profit. The company has committed over 380 billion yuan (US$56.5 billion) to AI infrastructure over three years, a move aimed at positioning Alibaba for long-term growth amid a challenging macroeconomic environment.

The Hang Seng index rose 0.7% on Wednesday, reflecting broader market strength as Alibaba shares recovered following the insider purchases.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT